{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T03:49:32Z","timestamp":1675223372113},"reference-count":37,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.03.048","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:53:33Z","timestamp":1522126413000},"page":"2427-2434","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses"],"prefix":"10.1016","volume":"36","author":[{"given":"C\u00e9dric","family":"Cheminay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constanze","family":"Bernig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Br\u00fcckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Feigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Suter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.03.048_b0005","doi-asserted-by":"crossref","first-page":"90ps27","DOI":"10.1126\/scitranslmed.3001880","article-title":"Development of newborn and infant vaccines","volume":"3","author":"Sanchez-Schmitz","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.03.048_b0010","unstructured":"Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. The epidemiology of smallpox. In: Smallpox and its eradication, Geneva; 1988. p. 169\u2013209."},{"key":"10.1016\/j.vaccine.2018.03.048_b0015","doi-asserted-by":"crossref","first-page":"e1003756","DOI":"10.1371\/journal.ppat.1003756","article-title":"An increasing danger of zoonotic orthopoxvirus infections","volume":"9","author":"Shchelkunov","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.03.048_b0020","unstructured":"WHO. Monkeypox. WHO fact sheet N\u00b0 16; 2011. <http:\/\/www.whoint\/mediacentre\/factsheets\/fs161\/en\/>."},{"key":"10.1016\/j.vaccine.2018.03.048_b0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri1394","article-title":"Neonatal adaptive immunity comes of age","volume":"4","author":"Adkins","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-5699(99)01548-0","article-title":"Neonatal immunity: how well has it grown up?","volume":"21","author":"Marshall-Clarke","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2018.03.048_b0035","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/eji.200838620","article-title":"Safety and efficacy of neonatal vaccination","volume":"39","author":"Demirjian","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0045","doi-asserted-by":"crossref","DOI":"10.1007\/s00281-017-0654-9","article-title":"Vaccine responses in newborns","author":"Saso","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0050","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.271.5256.1728","article-title":"Induction of TH1 and TH2 immunity in neonatal mice","volume":"271","author":"Forsthuber","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.03.048_b0055","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.vaccine.2010.12.083","article-title":"Antibody responses in adult and neonatal BALB\/c mice to immunization with novel Bordetella pertussis vaccine formulations","volume":"29","author":"Gracia","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0060","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1128\/JVI.74.6.2620-2627.2000","article-title":"Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization","volume":"74","author":"Hassett","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0065","doi-asserted-by":"crossref","first-page":"e3683","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.03.048_b0070","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.178.6.3695","article-title":"Induction of protective immunity to Listeria monocytogenes in neonates","volume":"178","author":"Kollmann","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.micinf.2007.10.010","article-title":"Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge","volume":"10","author":"Nascimento","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2018.03.048_b0080","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2010.06.089","article-title":"Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies","volume":"28","author":"Ramirez","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2009.09.087","article-title":"Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice","volume":"28","author":"Ranganathan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virol.2010.06.050","article-title":"Immunization of neonatal mice with LAMP\/p55 HIV gag DNA elicits robust immune responses that last to adulthood","volume":"406","author":"Rigato","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.03.048_b0095","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/icb.2009.31","article-title":"Salmonella enterica serovar Typhi live vector vaccines finally come of age","volume":"87","author":"Galen","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1348-0421.2011.00322.x","article-title":"Attenuated Listeria monocytogenes vaccine vectors expressing influenza A nucleoprotein: preclinical evaluation and oral inoculation of volunteers","volume":"55","author":"Johnson","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0105","first-page":"65","article-title":"Clinical analysis of 18 children with disseminated Bacille Calmette-Guerin infection","volume":"48","author":"Li","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.vaccine.2018.03.048_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","article-title":"DNA vaccines: an historical perspective and view to the future","volume":"239","author":"Liu","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2018.03.048_b0115","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1016\/j.vaccine.2009.05.095","article-title":"Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain","volume":"27","author":"Suter","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0120","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"von","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0125","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2009.06.105","article-title":"Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model","volume":"27","author":"Garza","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0130","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2018.03.048_b0135","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0140","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1016\/j.vaccine.2005.08.037","article-title":"Genetic stability of recombinant MVA-BN","volume":"24","author":"Timm","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.03.048_b0145","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"Parker","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2018.03.048_b0150","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.4049\/jimmunol.172.10.6304","article-title":"Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice","volume":"172","author":"Franchini","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0155","doi-asserted-by":"crossref","first-page":"e9659","DOI":"10.1371\/journal.pone.0009659","article-title":"Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice","volume":"5","author":"Lauterbach","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.03.048_b0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0165","doi-asserted-by":"crossref","first-page":"e1000480","DOI":"10.1371\/journal.ppat.1000480","article-title":"Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome","volume":"5","author":"Delaloye","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2018.03.048_b0170","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1128\/JVI.01190-07","article-title":"Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses","volume":"81","author":"Waibler","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0175","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1099\/vir.0.80660-0","article-title":"An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model","volume":"86","author":"Law","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.03.048_b0180","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.03.048_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18304043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T12:59:17Z","timestamp":1529931557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18304043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":37,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X18304043"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}